Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/25766
Title: Antilipopolysaccharide II: An antibody protective against fatal melioidosis
Authors: Chadarat Charuchaimontri
Yupin Suputtamongkol
Churairat Nilakul
Wipada Chaowagul
Ploenchan Chetchotisakd
Nimit Lertpatanasuwun
Sunanta Intaranongpai
Paul J. Brett
Donald E. Woods
Mahidol University
Sappasitthiprasong Hospital
Khon Kaen University
Srisaket Hospital
Surin Hospital
Health Sciences Centre Calgary
Keywords: Medicine
Issue Date: 1-Jan-1999
Citation: Clinical Infectious Diseases. Vol.29, No.4 (1999), 813-818
Abstract: This was a study of IgG antibody responses to two S-type lipopolysaccharides (LPS I and LPS II) and flagellin of Burkholderia pseudomallei in patients with melioidosis. The specificity of these antibodies was 91.7%, 90.3%, and 93.8%, respectively, when compared to responses in a population where the organism is not endemic. Only the level of antibody to LPS II (anti-LPS II) was significantly higher in patients who survived than in those who died, as well as in patients with nonsepticemic vs. septicemic melioidosis. Results of logistic regression analysis, controlled for confounding factors such as duration of illness before treatment and bacteremic status, confirmed that a high level of anti-LPS II was a significant factor protective against fatal melioidosis. Thus, LPS II of B. pseudomallei would be a potentially useful component of a vaccine developed against fatal melioidosis. Further studies are in progress to determine the level of this antibody among those with asymptomatic infection in areas where melioidosis is endemic.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0033509738&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/25766
ISSN: 10584838
Appears in Collections:Scopus 1991-2000

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.